RMD

ResMed
D

RMD

Arincen97/100B

ResMed company profile

CEO
Michael J. Farrell
Employees
11,370
Headquarters
9001 Spectrum Center Boulevard, San Diego, CA 92123, US
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO date
2 Jun 1995
Stock exchange
NYSE
ISIN
US7611521078

Website:resmed.com

About the company

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

Employees

ResMed had about 11,370 employees at the end of fiscal year 2026 (30 June 2026), by its annual report. That is 7.3% more than a year before.

Employees Change on the year
Fiscal yearEmployeesChange on the yearRevenue per employeeNet income per employee
FY202611,370+7.26%497.22K USD133.97K USD
FY202510,600+6.21%485.50K USD132.14K USD
FY20249,980-1.58%469.47K USD102.30K USD
FY202310,140+24.26%416.47K USD88.52K USD
FY20228,160+2.38%438.50K USD95.52K USD
FY20217,970+2.57%401.11K USD59.54K USD
FY20207,770+7.32%380.57K USD80.01K USD
FY20197,240+21.89%360.02K USD55.88K USD
FY20185,940-2.30%393.97K USD53.13K USD
FY20176,080+15.81%339.92K USD56.30K USD
FY20165,250+20.97%350.23K USD67.13K USD
FY20154,340+5.85%386.85K USD81.31K USD
FY20144,100+5.13%379.26K USD84.21K USD
FY20133,900+5.41%388.32K USD78.75K USD
FY20123,700+7.25%369.87K USD68.88K USD
FY20113,450+7.81%360.33K USD65.79K USD
FY20103,200+10.34%341.36K USD59.40K USD
FY20092,900+7.41%317.49K USD50.50K USD
FY20082,7000.00%309.41K USD40.85K USD
FY20072,700+8.00%265.31K USD24.56K USD
FY20062,500+29.74%242.80K USD35.28K USD
FY20051,927+26.78%220.81K USD33.62K USD
FY20041,520+3.83%223.25K USD37.69K USD
FY20031,464+17.12%186.86K USD31.24K USD
FY20021,250+31.16%163.26K USD30.00K USD
FY2001953+57.52%162.81K USD12.20K USD
FY2000605+26.83%191.10K USD36.74K USD
FY1999477+27.88%185.74K USD33.75K USD
FY1998373+38.15%178.28K USD28.42K USD
FY1997270+17.90%182.22K USD27.78K USD
FY1996229—151.09K USD19.65K USD

Employees at each fiscal year end, as the company reports them in its annual report (10-K); revenue and net income per employee are the fiscal year's over that count.

Who owns ResMed

Institutions such as funds, banks and insurers held 69.9% of ResMed's shares on 30 June 2026, 921 of them reporting holdings to the SEC; the rest is held by individual investors and other shareholders.

Institutions 69.9%Other shareholders 30.1%

Common questions about ResMed

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.